시장보고서

상품코드

1654167

세계의 혈액 가온기 시장 - 규모, 점유율, 동향 분석 보고서 : 유형별, 제품별, 유량별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Blood Warmer Market Size, Share & Trends Analysis Report By Type (Hardware, Consumables), By Product (Portable Blood Warmer, Non-portable Blood Warmer), By Flow Rate, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2025년 01월 | 리서치사:

Grand View Research | 페이지 정보: 영문 140 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈액가온기 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 혈액 가온기 세계 시장 규모는 2025-2030년 동안 8.61%의 연평균 복합 성장률(CAGR)을 기록해 2030년까지 3,834억 3,000만 달러에 이를 전망입니다. 교통사고, 재난, 기타 부상 발생 건수 증가, 저체온증 환자 부담 증가, 극단적인 온도환경에서 작동하는 외래서비스 및 군사/방위부문에서의 혈액가온기 수요 증가는 예측기간 동안 이러한 디바이스 시장 수요를 촉진할 것으로 예상됩니다.

최근 COVID-19의 대유행은 세계 입원의 급증과 관련이 있으며, 이는 시장에 긍정적 영향을 미칠 것으로 예상됩니다. 주입 요법 수요는 이 기간에 크게 급증했습니다. 이것은 수액을 체온으로 상승시키고 환자의 회복을 가속화하고 수액 충격의 위험을 줄이는 데 사용되는 혈액 가온기 장비 수요를 높이는 주요 요인 중 하나입니다.

게다가 다양한 제조업체들이 시장에서 골격을 강화하기 위해 M&A, 제휴, 제품 출시 등의 전략을 채택하고 있습니다. 예를 들어, 덴마크의 의료기술 기업 MEQU는 2020년 12월, 컴팩트한 혈액 및 수액 가온 시스템 M Warmer System 전용 새로운 배터리 Power Pack을 발매했습니다. 이 시스템은 병원 전 구급 현장에서 일반적으로 사용됩니다. 이러한 제품의 출시는 예측 기간 동안 시장을 촉진할 것으로 예상됩니다.

혈액 가온기 시장 보고서 하이라이트

비 휴대용 혈액 - 주입 가온기 부문은 2024년에 가장 큰 시장 점유율을 차지했습니다. 교통사고, 총창, 재난 발생률 증가가 부문 성장의 원동력이 될 것으로 예측됩니다.
수술 부문은 2024년 36.69%의 최대 점유율을 차지했습니다. 앞으로 몇 년동안 가장 빠르게 성장할 것으로 예상됩니다.
하드웨어 부문은 2024년에 가장 큰 점유율을 차지했습니다. 또한 향후 수년간 CAGR 8.88%로 급성장할 것으로 예측되고 있습니다.
급속/고속 유동 가온기 부문은 시장을 독점하고 예측 기간 동안 가장 빠른 CAGR 9.31%로 성장할 것으로 예측됩니다.
병원/클리닉 부문은 2024년 66.44%의 최대 점유율을 차지했습니다. 병원 및 클리닉은 혈액 가온기의 주요 최종 사용자입니다.
북미 혈액 가온기 시장은 2024년 45.47% 이상의 세계 최대 수익 점유율을 차지했습니다.

부문 대시보드
세계의 혈액 가온기 시장 변동 분석
세계의 혈액 가온기 시장 규모와 동향 분석, 최종 용도별, 2018-2030년
병원/클리닉
- 병원/클리닉 시장 추정·예측, 2018-2030년
외래 서비스
- 외래 서비스 시장 추정·예측, 2018-2030년
방위
- 방위 시장 추정·예측, 2018-2030년
구조대
- 구조대 시장 추정·예측, 2018-2030년

제7장 혈액 가온기 시장 : 유량별, 추정·동향 분석

부문 대시보드
세계의 혈액 가온기 시장 변동 분석
세계의 혈액 가온기 시장 규모와 동향 분석, 유량별, 2018-2030년
급속/고속 흐름 가온기
루틴/표준 플로우 가온기

제8장 혈액가온기 시장 : 유형별, 추정·동향 분석

부문 대시보드
세계의 혈액 가온기 시장 변동 분석
세계의 혈액 가온기 시장 규모와 동향 분석, 유형별, 2018-2030년
하드웨어
소모품

제9장 혈액 가온기 시장 : 지역별, 추정·동향 분석

지역 대시보드
시장 규모와 예측과 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 인도
- 중국
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제10장 경쟁 구도

시장 진출기업의 분류
주요 기업 프로파일
- GENTHERM
- Belmont Medical Technologies
- 3M
- ICU Medical, Inc.
- TSC Life
- MEQU.
- Estill Medical Technologies, Inc
- Quality In Flow Ltd(QinFlow)
- Biegler GmbH
- Labtron Equipment Ltd.
- North American Rescue, LLC
히트맵 분석/기업시장 포지셔닝 분석
2024년 기업의 시장 점유율 추정 분석
기타 주요 시장 진출기업 일람

JHS 25.03.10

Blood Warmers Market Growth & Trends:

The global blood warmer market size is expected to reach USD 383.43 billion by 2030, registering a CAGR of 8.61% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidences of road accidents, mishaps and other injuries, rising burden of hypothermia cases along with growing demand for blood warmers from ambulatory services and military/defense sectors, operating in extreme temperature environments are expected to propel the market demand for such devices over the forecast period.

Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization globally, this is expected to have a positive impact on the market. The demand for infusion therapy surged significantly during this period. This is one of the key factors driving up demand for blood warmer devices, which are used to raise fluids to body temperature, speed up patient recovery, and reduce the danger of transfusion shock.

Moreover, various manufacturers are adopting strategies such as mergers and acquisitions, partnerships, and product launches to strengthen their foothold in the market. For instance, in December 2020, Danish MedTech Company MEQU released the Power Pack, a new battery for its M Warmer System, a compact blood and IV fluid-warming systems. The system is commonly used in prehospital emergency settings. Such product launches are expected to propel the market over the forecast period.

Blood Warmers Market Report Highlights:

The non-portable blood-IV fluid warmers segment held the largest market share in 2024. The growing incidence of road accidents, gunshot wounds, and mishaps is expected to drive segment growth.
The surgery segment held the largest share of 36.69% in 2024. It is anticipated to grow fastest in the coming years.
The hardware segment held the largest share in 2024. It is also anticipated to grow fastest at a CAGR of 8.88% in the coming years.
The rapid/fast flow warmers segment dominated the market and is expected to grow at the fastest CAGR of 9.31% over the forecast period.
The hospitals/ clinics segment held the largest share of 66.44% in 2024. Hospitals and clinics are the primary end users of blood warmers.
North America blood warmer market held the largest revenue share globally of more than 45.47% in 2024.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Blood Warmer Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising incidence of cold weather injuries
  - 3.2.1.2. Increasing number of surgeries and trauma cases
  - 3.2.1.3. Growing demand for blood warmer from ambulance services, military & defense sector
  - 3.2.1.4. Advancements in blood warmer
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Recalls of blood warmer devices
  - 3.2.2.2. Stringent regulations associated with blood warmer devices
- 3.2.3. Market opportunity analysis
  - 3.2.3.1. Growing demand for portable blood warmer
  - 3.2.3.2. Distribution agreements for blood warmer
  - 3.2.3.3. Expansion opportunities in cold weather countries
- 3.2.4. Market challenge analysis
  - 3.2.4.1. Complications and adverse events associated with the use of blood warmer
3.3. Blood Warmer Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. Blood Warmer Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Blood Warmer Market Movement Analysis
4.3. Global Blood Warmer Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Portable Blood/IV Warmers
- 4.4.1. Portable blood/iv warmers market estimates and forecast 2018 to 2030 (USD Million)
4.5. Non-portable Blood/IV Warmers
- 4.5.1. Non-portable blood/iv warmers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Blood Warmer Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Blood Warmer Market Movement Analysis
5.3. Global Blood Warmer Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Surgery
- 5.4.1. Surgery market estimates and forecast 2018 to 2030 (USD Million)
5.5. Pediatrics
- 5.5.1. Pediatrics market estimates and forecast 2018 to 2030 (USD Million)
5.6. Acute Care
- 5.6.1. Acute care market estimates and forecast 2018 to 2030 (USD Million)
5.7. Homecare
- 5.7.1. Homecare market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Blood Warmer Devices: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Blood Warmer Market Movement Analysis
6.3. Global Blood Warmer Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals/Clinics
- 6.4.1. Hospitals/clinics market estimates and forecast 2018 to 2030 (USD Million)
6.5. Ambulatory Services
- 6.5.1. Ambulatory services market estimates and forecast 2018 to 2030 (USD Million)
6.6. Defense Forces
- 6.6.1. Defense forces market estimates and forecast 2018 to 2030 (USD Million)
6.7. Rescue Forces
- 6.7.1. Rescue forces market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Blood Warmer Market: Flow Rate Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Blood Warmer Market Movement Analysis
7.3. Global Blood Warmer Market Size & Trend Analysis, by Flow Rate, 2018 to 2030 (USD Million)
7.4. Rapid/Fast Flow Warmers
- 7.4.1. Rapid/fast flow warmers market estimates and forecast 2018 to 2030 (USD Million)
7.5. Routine/Standard Flow Warmers
- 7.5.1. Routine/standard flow warmers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Blood Warmer Market: Type Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Global Blood Warmer Market Movement Analysis
8.3. Global Blood Warmer Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
8.4. Hardware
- 8.4.1. Hardware market estimates and forecast 2018 to 2030 (USD Million)
8.5. Consumables
- 8.5.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Blood Warmer Market: Regional Estimates & Trend Analysis

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
- 9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key country dynamics
  - 9.3.2.2. Competitive scenario
  - 9.3.2.3. Regulatory framework
  - 9.3.2.4. Reimbursement scenario
  - 9.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 9.3.3. Canada
  - 9.3.3.1. Key country dynamics
  - 9.3.3.2. Competitive scenario
  - 9.3.3.3. Regulatory framework
  - 9.3.3.4. Reimbursement scenario
  - 9.3.3.5. Canada market estimates and forecasts, 2018 - 2030
- 9.3.4. Mexico
  - 9.3.4.1. Key country dynamics
  - 9.3.4.2. Competitive scenario
  - 9.3.4.3. Regulatory framework
  - 9.3.4.4. Reimbursement scenario
  - 9.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
9.4. Europe
- 9.4.1. UK
  - 9.4.1.1. Key country dynamics
  - 9.4.1.2. Competitive scenario
  - 9.4.1.3. Regulatory framework
  - 9.4.1.4. Reimbursement scenario
  - 9.4.1.5. UK market estimates and forecasts, 2018 - 2030
- 9.4.2. Germany
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Competitive scenario
  - 9.4.2.3. Regulatory framework
  - 9.4.2.4. Reimbursement scenario
  - 9.4.2.5. Germany market estimates and forecasts, 2018 - 2030
- 9.4.3. France
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Competitive scenario
  - 9.4.3.3. Regulatory framework
  - 9.4.3.4. Reimbursement scenario
  - 9.4.3.5. France market estimates and forecasts, 2018 - 2030
- 9.4.4. Italy
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. Competitive scenario
  - 9.4.4.3. Regulatory framework
  - 9.4.4.4. Reimbursement scenario
  - 9.4.4.5. Italy market estimates and forecasts, 2018 - 2030
- 9.4.5. Spain
  - 9.4.5.1. Key country dynamics
  - 9.4.5.2. Competitive scenario
  - 9.4.5.3. Regulatory framework
  - 9.4.5.4. Reimbursement scenario
  - 9.4.5.5. Spain market estimates and forecasts, 2018 - 2030
- 9.4.6. Denmark
  - 9.4.6.1. Key country dynamics
  - 9.4.6.2. Competitive scenario
  - 9.4.6.3. Regulatory framework
  - 9.4.6.4. Reimbursement scenario
  - 9.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 9.4.7. Sweden
  - 9.4.7.1. Key country dynamics
  - 9.4.7.2. Competitive scenario
  - 9.4.7.3. Regulatory framework
  - 9.4.7.4. Reimbursement scenario
  - 9.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 9.4.8. Norway
  - 9.4.8.1. Key country dynamics
  - 9.4.8.2. Competitive scenario
  - 9.4.8.3. Regulatory framework
  - 9.4.8.4. Reimbursement scenario
  - 9.4.8.5. Norway market estimates and forecasts, 2018 - 2030
9.5. Asia Pacific
- 9.5.1. Japan
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Competitive scenario
  - 9.5.1.3. Regulatory framework
  - 9.5.1.4. Reimbursement scenario
  - 9.5.1.5. Japan market estimates and forecasts, 2018 - 2030
- 9.5.2. India
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Competitive scenario
  - 9.5.2.3. Regulatory framework
  - 9.5.2.4. Reimbursement scenario
  - 9.5.2.5. India market estimates and forecasts, 2018 - 2030
- 9.5.3. China
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Competitive scenario
  - 9.5.3.3. Regulatory framework
  - 9.5.3.4. Reimbursement scenario
  - 9.5.3.5. China market estimates and forecasts, 2018 - 2030
- 9.5.4. South Korea
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Competitive scenario
  - 9.5.4.3. Regulatory framework
  - 9.5.4.4. Reimbursement scenario
  - 9.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 9.5.5. Australia
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Competitive scenario
  - 9.5.5.3. Regulatory framework
  - 9.5.5.4. Reimbursement scenario
  - 9.5.5.5. Australia market estimates and forecasts, 2018 - 2030
- 9.5.6. Thailand
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Competitive scenario
  - 9.5.6.3. Regulatory framework
  - 9.5.6.4. Reimbursement scenario
  - 9.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
9.6. Latin America
- 9.6.1. Brazil
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Competitive scenario
  - 9.6.1.3. Regulatory framework
  - 9.6.1.4. Reimbursement scenario
  - 9.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 9.6.2. Argentina
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Competitive scenario
  - 9.6.2.3. Regulatory framework
  - 9.6.2.4. Reimbursement scenario
  - 9.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
9.7. MEA
- 9.7.1. South Africa
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Competitive scenario
  - 9.7.1.3. Regulatory framework
  - 9.7.1.4. Reimbursement scenario
  - 9.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 9.7.2. Saudi Arabia
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Competitive scenario
  - 9.7.2.3. Regulatory framework
  - 9.7.2.4. Reimbursement scenario
  - 9.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 9.7.3. UAE
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Competitive scenario
  - 9.7.3.3. Regulatory framework
  - 9.7.3.4. Reimbursement scenario
  - 9.7.3.5. UAE market estimates and forecasts, 2018 - 2030
- 9.7.4. Kuwait
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Competitive scenario
  - 9.7.4.3. Regulatory framework
  - 9.7.4.4. Reimbursement scenario
  - 9.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Key Company Profiles
- 10.2.1. GENTHERM
  - 10.2.1.1. Company overview
  - 10.2.1.2. Financial performance
  - 10.2.1.3. Product benchmarking
  - 10.2.1.4. Strategic initiatives
- 10.2.2. Belmont Medical Technologies
  - 10.2.2.1. Company overview
  - 10.2.2.2. Financial performance
  - 10.2.2.3. Product benchmarking
  - 10.2.2.4. Strategic initiatives
- 10.2.3. 3M
  - 10.2.3.1. Company overview
  - 10.2.3.2. Financial performance
  - 10.2.3.3. Product benchmarking
  - 10.2.3.4. Strategic initiatives
- 10.2.4. ICU Medical, Inc.
  - 10.2.4.1. Company overview
  - 10.2.4.2. Financial performance
  - 10.2.4.3. Product benchmarking
  - 10.2.4.4. Strategic initiatives
- 10.2.5. TSC Life
  - 10.2.5.1. Company overview
  - 10.2.5.2. Financial performance
  - 10.2.5.3. Product benchmarking
  - 10.2.5.4. Strategic initiatives
- 10.2.6. MEQU.
  - 10.2.6.1. Company overview
  - 10.2.6.2. Financial performance
  - 10.2.6.3. Product benchmarking
  - 10.2.6.4. Strategic initiatives
- 10.2.7. Estill Medical Technologies, Inc
  - 10.2.7.1. Company overview
  - 10.2.7.2. Financial performance
  - 10.2.7.3. Product benchmarking
  - 10.2.7.4. Strategic initiatives
- 10.2.8. Quality In Flow Ltd (QinFlow)
  - 10.2.8.1. Company overview
  - 10.2.8.2. Financial performance
  - 10.2.8.3. Product benchmarking
  - 10.2.8.4. Strategic initiatives
- 10.2.9. Biegler GmbH
  - 10.2.9.1. Company overview
  - 10.2.9.2. Financial performance
  - 10.2.9.3. Product benchmarking
  - 10.2.9.4. Strategic initiatives
- 10.2.10. Labtron Equipment Ltd.
  - 10.2.10.1. Company overview
  - 10.2.10.2. Financial performance
  - 10.2.10.3. Product benchmarking
  - 10.2.10.4. Strategic initiatives
- 10.2.11. North American Rescue, LLC
  - 10.2.11.1. Company overview
  - 10.2.11.2. Financial performance
  - 10.2.11.3. Product benchmarking
  - 10.2.11.4. Strategic initiatives
10.3. Heat Map Analysis/ Company Market Position Analysis
10.4. Estimated Company Market Share Analysis, 2024
10.5. List of Other Key Market Players